BIOMAKERS
City Of Dover, County Of Kent, US · Delaware corporation · 1 known investors
Find your way into BIOMAKERS
411 people in our graph share verified history with the BIOMAKERS team — schools, employers, funds. One of them is your warm intro.
Arturo Litvinunlockedknows Nicolas Kirchuk · together at University of Buenos Aires (overlapped)
×2knows the team · via University of Buenos Aires
×8knows the team · via Universitat Pompeu Fabra
knows the team · via Universidad del Salvador
Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.
Founders & leadership
NK

Nicolas KirchukinCEO & Co-FounderNicolas Kirchuk is co-founder and CEO of Biomakers, a precision oncology company that develops genomic testing, real-world data platforms, and AI tools for cancer diagnosis, treatment, and drug development across Latin America. He was recognized by Forbes as an outstanding young entrepreneur in 2018 and has led Biomakers to establish sequencing facilities in Mexico, Brazil, and Argentina.
RJ
Ruben Javier SalanovaNamed on SEC filing
JM
Juan Manuel MarroneSecretary
Board
CV

PF
Pablo FernandezBoard director
CD
Clarisa Diana LifsicDirector, Treasurer
Investors · 1
Funding
SEC filings, press & company announcements$13.9M disclosed across 2 rounds · 2024–2026
- $8MraisedJan 2026 · 2 sourcesSource ↗
▶$5.9MraisedApr 2026 · 7 investors · BiotechnologyRule 506(b)
▶$5.9MraisedApr 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ruben Javier SalanovaDirector
- Pablo FernandezDirector
- Juan Manuel MarroneExecutive Officer
- Consuelo ValverdeDirector
- Clarisa Diana LifsicExecutive Officer, Director
- Nicolas KirchukExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $5.9M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does BIOMAKERS do?
- Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.
- Who founded BIOMAKERS?
- BIOMAKERS was founded by Nicolas Kirchuk.
- Who are BIOMAKERS's investors?
- BIOMAKERS's investors include Oncology Ventures.
- How much funding has BIOMAKERS raised?
- BIOMAKERS has disclosed $13.9M raised across 2 rounds.
- Where is BIOMAKERS headquartered?
- BIOMAKERS is headquartered in City Of Dover, County Of Kent, US.

